Nurix Therapeutics (NRIX) Revenue (2019 - 2025)
Historic Revenue for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $13.6 million.
- Nurix Therapeutics' Revenue rose 220.57% to $13.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $84.0 million, marking a year-over-year increase of 5395.33%. This contributed to the annual value of $84.0 million for FY2025, which is 5395.33% up from last year.
- Per Nurix Therapeutics' latest filing, its Revenue stood at $13.6 million for Q4 2025, which was up 220.57% from $7.9 million recorded in Q3 2025.
- Nurix Therapeutics' 5-year Revenue high stood at $44.1 million for Q2 2025, and its period low was $5.0 million during Q1 2021.
- In the last 5 years, Nurix Therapeutics' Revenue had a median value of $12.3 million in 2024 and averaged $14.2 million.
- Its Revenue has fluctuated over the past 5 years, first tumbled by 6058.16% in 2024, then skyrocketed by 26434.01% in 2025.
- Quarter analysis of 5 years shows Nurix Therapeutics' Revenue stood at $7.4 million in 2021, then fell by 8.29% to $6.8 million in 2022, then surged by 123.49% to $15.2 million in 2023, then decreased by 12.37% to $13.3 million in 2024, then increased by 2.21% to $13.6 million in 2025.
- Its Revenue stands at $13.6 million for Q4 2025, versus $7.9 million for Q3 2025 and $44.1 million for Q2 2025.